Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sunil Krishnan

Showing results (271-280 of 337) with videos related to

Pageof 34
Sort By:
Nanomedicine (London, England)|September 26, 2013
Targeting pancreatic cancer with magneto-fluorescent theranostic gold nanoshellsWenxue Chen, Ciceron Ayala-Orozco, Nrusingh C Biswal, et al.
Acta Oncologica (Stockholm, Sweden)|January 23, 2015
Paraneoplastic thrombocytosis independently predicts poor prognosis in patients with locally advanced pancreatic cancerAwalpreet S Chadha, Esengul Kocak-Uzel, Prajnan Das, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 28, 2015
Ablative Radiotherapy Doses Lead to a Substantial Prolongation of Survival in Patients With Inoperable Intrahepatic Cholangiocarcinoma: A Retrospective Dose Response AnalysisRanda Tao, Sunil Krishnan, Priya R Bhosale, et al.
International Journal of Radiation Oncology, Biology, Physics|January 22, 2008
Patterns of locoregional recurrence after surgery and radiotherapy or chemoradiation for rectal cancerTse-Kuan Yu, Priya R Bhosale, Christopher H Crane, et al.
International Journal of Radiation Oncology, Biology, Physics|June 28, 2014
Interobserver variability in target definition for hepatocellular carcinoma with and without portal vein thrombus: radiation therapy oncology group consensus guidelinesTheodore S Hong, Walter R Bosch, Sunil Krishnan, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|September 3, 2013
Serum carbohydrate antigen 19-9 represents a marker of response to neoadjuvant therapy in patients with borderline resectable pancreatic cancerChing-Wei D Tzeng, Aparna Balachandran, Mediha Ahmad, et al.
Science Advances|November 11, 2022
Pancreatic tumor microenvironmental acidosis and hypoxia transform gold nanorods into cell-penetrant particles for potent radiosensitizationPradipta Ranjan Rauta, Yuri Mackeyev, Keith Sanders, et al.
Oncology|June 9, 2012
Localized gastric cancer treated with chemoradation without surgery: UTMD Anderson Cancer Center experienceAkihiro Suzuki, Lianchun Xiao, Takashi Taketa, et al.
Clinical and Translational Radiation Oncology|March 30, 2018
Definitive radiation therapy for hepatocellular carcinoma with portal vein tumor thrombusEmma B Holliday, Randa Tao, Zachary Brownlee, et al.
American Journal of Clinical Oncology|June 7, 2006
Clinical and pathologic predictors of locoregional recurrence, distant metastasis, and overall survival in patients treated with chemoradiation and mesorectal excision for rectal cancerPrajnan Das, John M Skibber, Miguel A Rodriguez-Bigas, et al.
Pageof 34

Showing results (271-280 of 337) with videos related to

Sort By:
Pageof 34
Nanomedicine (London, England)|September 26, 2013
Targeting pancreatic cancer with magneto-fluorescent theranostic gold nanoshellsWenxue Chen, Ciceron Ayala-Orozco, Nrusingh C Biswal, et al.
Acta Oncologica (Stockholm, Sweden)|January 23, 2015
Paraneoplastic thrombocytosis independently predicts poor prognosis in patients with locally advanced pancreatic cancerAwalpreet S Chadha, Esengul Kocak-Uzel, Prajnan Das, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 28, 2015
Ablative Radiotherapy Doses Lead to a Substantial Prolongation of Survival in Patients With Inoperable Intrahepatic Cholangiocarcinoma: A Retrospective Dose Response AnalysisRanda Tao, Sunil Krishnan, Priya R Bhosale, et al.
International Journal of Radiation Oncology, Biology, Physics|January 22, 2008
Patterns of locoregional recurrence after surgery and radiotherapy or chemoradiation for rectal cancerTse-Kuan Yu, Priya R Bhosale, Christopher H Crane, et al.
International Journal of Radiation Oncology, Biology, Physics|June 28, 2014
Interobserver variability in target definition for hepatocellular carcinoma with and without portal vein thrombus: radiation therapy oncology group consensus guidelinesTheodore S Hong, Walter R Bosch, Sunil Krishnan, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|September 3, 2013
Serum carbohydrate antigen 19-9 represents a marker of response to neoadjuvant therapy in patients with borderline resectable pancreatic cancerChing-Wei D Tzeng, Aparna Balachandran, Mediha Ahmad, et al.
Science Advances|November 11, 2022
Pancreatic tumor microenvironmental acidosis and hypoxia transform gold nanorods into cell-penetrant particles for potent radiosensitizationPradipta Ranjan Rauta, Yuri Mackeyev, Keith Sanders, et al.
Oncology|June 9, 2012
Localized gastric cancer treated with chemoradation without surgery: UTMD Anderson Cancer Center experienceAkihiro Suzuki, Lianchun Xiao, Takashi Taketa, et al.
Clinical and Translational Radiation Oncology|March 30, 2018
Definitive radiation therapy for hepatocellular carcinoma with portal vein tumor thrombusEmma B Holliday, Randa Tao, Zachary Brownlee, et al.
American Journal of Clinical Oncology|June 7, 2006
Clinical and pathologic predictors of locoregional recurrence, distant metastasis, and overall survival in patients treated with chemoradiation and mesorectal excision for rectal cancerPrajnan Das, John M Skibber, Miguel A Rodriguez-Bigas, et al.
Pageof 34